Financial statements Apteopharm
Balance sheet of Apteopharm
Company age:
Age:
10 y. 9 m. 26 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of APTEOPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 62 503,80 | 62 249,17 | 63 457,75 | 64 394,23 | 101 369,56 | 87 439,96 |
| A. Fixed assets | - | 0,00 | 0,00 | - | 60 000,00 | 60 000,00 |
| B. Current assets | 62 503,80 | 62 249,17 | 63 457,75 | 64 394,23 | 41 369,56 | 27 439,96 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 62 503,80 | 62 249,17 | 63 457,75 | 64 394,23 | 101 369,56 | 87 439,96 |
| A. Equity | -4 878,54 | -7 685,83 | -8 794,63 | 14 511,03 | 42 798,06 | 81 617,20 |
| B. Liabilities and provisions for liabilities | 67 382,34 | 69 935,00 | 72 252,38 | 49 883,20 | 58 571,50 | 5 822,76 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.